Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06650969
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-15
Brief Title:
China Diabetes Cognitive Dysfunction Early Diagnosis and Intervention Study China-DECODE Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
China Diabetes Cognitive Dysfunction Early Diagnosis and Intervention Study China-DECODE Study
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Type 2 diabetes T2D and dementia are both diseases with increasing incidence and prevalence globally leading to substantial economic burdens for families and society Notably diabetes significantly increases the risk of cognitive dysfunction which is classified into preclinical stage mild cognitive impairment and dementia based on the disease severity Cognitive dysfunction is a critical contributor to disability and mortality in elderly diabetes patients Early diagnosis and intervention are crucial for delaying disease progression enhancing treatment efficacy and mitigating the impact of dementia Currently research and clinical management of cognitive dysfunction in individuals with diabetes are in their infancy characterized by limitations such as single-center studies limited sample sizes inconsistent diagnostic criteria and insufficient data sharing Consequently clinical diagnosis and treatment strategies are underdeveloped medical staffs related knowledge is lacking and potential therapeutic targets remain unexplored In view of these problems and shortcomings the population cohort study is supposed to be carried out based on accurate diagnosis and constructed the high standard information and sample bank The study will establish the standard and quality system of T2D with cognitive dysfunction cohort study unified standards and norms The study will integrate the standard biological samples stratified acquisition function module homogeneity and precision of cognitive dysfunction in T2D and complete the construction of biological samples bank and clinical diagnosis and treatment information database The study will apply and develop brain structural and functional imaging technology to support precision diagnosis of cognitive dysfunction in T2D
Detailed Description:
The neuropsychological test battery are used to access the cognitive function of subjects in the study The laboratory examinations brain MRI and olfactory function measurements will be done in the screening period The samples such as plasma serum urine and faeces et al of the subjects will be collected in the study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None